|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2001-1-26
|
|
pubmed:abstractText |
Gene manipulation and cell vaccines represent innovative strategies to enhance the immunogenicity of cancer cells. We adopted a defective lentivirus derived from the human immunodeficiency virus (HIV)-1 backbone and carrying the enhanced green fluorescent protein (EGFP) gene to transduce primary human acute myelogenous leukemia (AML) and B-precursor acute lymphoblastic leukemia (ALL) cells.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0390-6078
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
86
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
13-6
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:11146564-Bone Marrow Cells,
pubmed-meshheading:11146564-Cell Cycle,
pubmed-meshheading:11146564-Cell Division,
pubmed-meshheading:11146564-Genes, Reporter,
pubmed-meshheading:11146564-Glycerol Kinase,
pubmed-meshheading:11146564-Green Fluorescent Proteins,
pubmed-meshheading:11146564-HIV-1,
pubmed-meshheading:11146564-Humans,
pubmed-meshheading:11146564-Leukemia, Myeloid, Acute,
pubmed-meshheading:11146564-Luminescent Proteins,
pubmed-meshheading:11146564-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:11146564-Promoter Regions, Genetic,
pubmed-meshheading:11146564-Transduction, Genetic,
pubmed-meshheading:11146564-Tumor Cells, Cultured
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Efficient lentiviral transduction of primary human acute myelogenous and lymphoblastic leukemia cells.
|
|
pubmed:affiliation |
Centro M. Tettamanti, Clinica Pediatrica Università di Milano Bicocca, Ospedale San Gerardo, Monza, Italy.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
